A Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar13¿ in Healthy Infants

Project: Other project

Project Details

StatusFinished
Effective start/end date2/8/17 → 2/7/21